Interestingly, recent findings from zonation fate-mapping animal models suggest liver cancer prevention strategies that leverage central-zonation-dependent mechanisms, particularly targeting Gstm3, which we also identified as a central-like tumour marker (Fig. 5b)36. This evidence concerns the gene GSTM3 and liver cancer.